Tìm kiếm
Emergent BioSolutions Inc
EBSThêm vào danh sách theo dõi
8.280USD
+0.010+0.12%
Đóng cửa 07/02, 13:00（ET）Báo giá bị trễ 15 phút
428.90MVốn hóa
LỗP/E TTM
Thêm thông tin về Emergent BioSolutions Inc Công ty
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Thông tin của Emergent BioSolutions Inc
Mã chứng khoánEBS
Tên công tyEmergent BioSolutions Inc
Ngày IPONov 15, 2006
Giám đốc điều hànhPapa (Joseph C)
Số lượng nhân viên900
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhNov 15
Địa chỉ300 Professional Dr
Thành phốGAITHERSBURG
Sàn giao dịch chứng khoánNASDAQ OMX NASDAQ Basic NYSE
Quốc giaUnited States of America
Mã bưu điện20879
Điện thoại12406313200
Trang webhttps://emergentbiosolutions.com/
Mã chứng khoánEBS
Ngày IPONov 15, 2006
Giám đốc điều hànhPapa (Joseph C)
Lãnh đạo công ty của Emergent BioSolutions Inc
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
267.95K
-1.48%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
153.92K
-1.31%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
145.03K
-1.20%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
114.67K
+22.10%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
89.36K
+28.36%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
79.44K
+31.90%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
59.03K
+16.71%
Xem thêm
Tên
Tên/Chức vụ
Chức vụ
Tỷ lệ sở hữu cổ phần
Thay đổi
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
304.82K
+61.58%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
267.95K
-1.48%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
165.29K
+63.09%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
153.92K
-1.31%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
145.03K
-1.20%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
116.59K
+85.86%
Câu hỏi thường gặp
Ai là năm cổ đông lớn nhất của Emergent BioSolutions Inc?
Năm cổ đông hàng đầu của Emergent BioSolutions Inc là: Mr. Joseph C. (Joe) Papa
Có bao nhiêu tổ chức nắm giữ cổ phiếu của Emergent BioSolutions Inc (EBS)?
Tính đến ngày 2026Q1, có 412 tổ chức nắm giữ cổ phiếu của Emergent BioSolutions Inc, với tổng giá trị thị trường khoảng 42.30M, chiếm 81.98% tổng số cổ phiếu. So với ngày 2025Q4, tỷ lệ cổ phần của các tổ chức đã tăng thêm -3370363.00.
Nguồn doanh thu lớn nhất của Emergent BioSolutions Inc là gì?
Vào ngày 2026Q1, bộ phận kinh doanh Commercial Product sales đã tạo ra doanh thu cao nhất cho Emergent BioSolutions Inc, đạt 223.30M, chiếm 30.06% tổng doanh thu.